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Background: Chronic cough is a common and distressing symptom. Gastro-oesophageal reflux is a common cause
of chronic cough however the symptom complex in cough is not confined to classic peptic symptoms. Dyspeptic
symptoms have previously been shown to respond to dietary modifications and weight loss. We hypothesised that
weight reduction maybe a useful non-pharmacological strategy in reducing reflux cough in the obese.
Methods: Subjects with cough were recruited from Hull Cough Clinic. They were randomised to one of two open
parallel groups; one receiving the traditional dietary modifications and the other weight reduction advice in the
form of an Energy Prescription (EP). Cough symptoms, using the Leicester cough questionnaire (LCQ) and dietary
intake were measured at the start and end of the study.
Results: Thirty-three patients were recruited and 20 patients completed the study. Mean weight loss was 3.1 kg
(p < 0.001) and reported an improvement in the LCQ (mean improvement 3.1); which is greater than the clinically
significant score of 1.3. . Moreover, secondary outcomes showed a significant association between baseline high
calorie (r = -0.24; p < 0.001) and fat intake (r = -0.36; p = 0.001), and LCQ scores.
Conclusion: A high calorie and fat intake is strongly correlated with cough score. Irrespective of diet, weight loss is
associated with a reduction in cough symptoms. Asking patients to lose weight by reducing fat and calorie intake
may be a simple strategy to ameliorate this intractable condition.
Trial Registration: The study was approved by the local research ethics committee (South Humber Local Research
Ethics Committee; REC04/Q1105/62). The study was registered with the Research and Development Department,
Clinical Governance Directorate, Hull and East Yorkshire Hospitals NHS Trust (reference number R0086).
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Cough is the most common complaint leading patients
to consult with primary care physicians [1,2]. Cough is a
vital protective mechanism for clearing foreign material
or excessive secretions from the airways. The common
cold is the most frequent cause of cough in the acute
(i.e., <3 weeks in duration) setting and is usually self-
limiting. However, a persistently troublesome chronic* Correspondence: jo.donaldson@hey.nhs.uk
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reproduction in any medium, provided the orcough (i.e., >8 weeks in duration) of obscure aetiology
has been shown to be one of the most common rea-
sons for new patient visits to respiratory physicians in
secondary/tertiary care [3].
Gastro-oesophageal reflux is a common cause of
chronic cough [4]. A number of studies have reported a
higher incidence of classic acid related reflux symptoms
(gastro-oesophageal reflux disease (GORD)) in over-
weight and obese people [5-8]. In a systematic review of
16 studies of GORD management, weight loss was asso-
ciated with improved oesophageal pH profiles and GORD
related symptoms [9]. We have recently demonstrated antd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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observed in clinical practice that weight gain can be asso-
ciated with the onset of chronic cough. The effect of
weight loss on cough has not been studied.
The traditional dietary advice given to GORD patients
is not concerned with weight loss, but is centred around
dietary modifications, for example avoidance of spicy
foods, coffee, alcohol and high fat foods [11,12]. How-
ever recent studies have been unable to confirm the
efficacy of such measures [9,13,14]. A systematic review
concluded that there was insufficient data to support or
refute common recommendations to change diet [15].
Thus the evidence base for such advice appears poor
and the prevailing opinion is summarised by DeVault
and Castell who suggest that traditional diet therapy
‘may benefit many patients with GORD, although these
changes alone are unlikely to control symptoms in the
majority of patients’ [16]. The current National Institute
of Clinical Excellence (NICE) guidance is more dismis-
sive “available trials of lifestyle advice to reduce symp-
toms of dyspepsia are small and inconclusive” and that
there is “no clear association between dyspepsia and
other lifestyle factors: smoking, alcohol, coffee, and diet”
[17]. Thus there is a conflict between traditional dietary
practice and the evidence for the role of conventional
dietary intervention in GORD.
The form of reflux leading to cough is different in
constitution, location and timing to that associated with
classic GORD symptoms such as heartburn [18]. These
reflux events may be extra-oesophageal, of a shorter dur-
ation and not necessarily acid in nature. The diagnosis
of such airway reflux relies on the clinical history, but
may be established by the use of validated, reproducible
and responsive questionnaires such as the Hull Airways
Reflux Questionnaire (HARQ) [19]. The differences
between airway reflux and classic GORD symptoms has
previously lead to diagnostic confusion with many pa-
tients being mislabelled as suffering from an asthmatic
or idiopathic cough.
We hypothesised that weight reduction may be a use-
ful non-pharmacological strategy for patients presenting
with chronic cough. We therefore undertook a study
comparing two dietetic strategies, weight loss and anti-
reflux, in obese patients with a positive HARQ response
indicating significant symptoms of airway reflux. As a
weight loss strategy we used the energy prescription
method (EP) as described by Frost et al. [20]. This was
compared with the traditional GORD anti-reflux diet
suggested within the Manual of Dietetic Practice [21] in
an open parallel group study.
Brief statement of findings
We assessed two different dietary regimens and whether
they would help attenuate cough reflux. We found thatweight reduction, irrespective of diet reduced cough
reflux symptoms and this has not been found before.
Methods
Patients were recruited from the Hull Cough Clinic at
Castle Hill Hospital. The study was approved by the local
research ethics committee (South Humber Local Research
Ethics Committee; REC04/Q1105/62). The study was reg-
istered with the Research and Development Department,
Clinical Governance Directorate, Hull and East Yorkshire
Hospitals NHS Trust (reference number R0086). The
study was completed between June 2005 and September
2009.
Patients
Patients were diagnosed as have cough secondary to
airway reflux based on the validated HARQ score of >13
[19]. This is represents the upper limit of normal on the
self-completed, fourteen component instrument. Based
on the WHO classification of obesity [22], patients with
a body mass index (BMI) >25 kg/m2 were asked whether
they wished to participate in a trial of dietary interven-
tion. Following informed consent patients were rando-
mised in a double-blinded manner using a Latin Square
fashion to one of two open parallel groups.
Intervention
One group received the traditional dietary modifications
consisting of personalised advice concerning eating
smaller meals at regular intervals; avoiding eating late at
night; avoiding bending/lifting or lying down after meals,
and general encouragement to lose weight by following a
balanced diet plan [23]. Excessive consumption of tea/
coffee/alcohol was to be avoided as was highly spiced or
irritant foods or particular foods known to exacerbate
symptoms. Sleeping in a semi-upright position or raising
the head of the bed to help prevent nocturnal symptoms
of reflux was encouraged [21].
The other group received dietary advice on weight re-
duction in the form of an EP diet [20]. The EP is calculated
using the individual’s basal metabolic rate (BMR) based on
age, gender and weight in kg, adding on a physical activity
level (PAL) based on gender and activity level to then
calculate estimated energy requirements (EER). The EER
then has 600 kcal subtracted. An individualised balanced
menu plan is then provided with guidance on portion sizes.
At baseline all patients had dietary and anthropometric
assessments and were advised on the dietary treatment
plan by a registered dietician (JS). Both groups were asked
to complete the Leicester Cough Questionnaire [24] and
5 day food diaries at the beginning and end of the 6 month
observation study period. All patients were reviewed at
monthly intervals when compliance was assessed and
dietary advice reinforced.
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Baseline and demographic data were expressed as mean
(± standard deviation (SD)) or median (interquartile range).
Post-intervention data were also similarly expressed. Statis-
tical comparisons of the effect of the interventions within
and between groups were carried out using Wilcoxon-
signed rank and Kruskal-Wallis test respectively. Due to the
high drop out rate and inequality between the two groups
modified intention to treat (ITT) analyses was performed.
Missing observations were imputed using last outcome car-
ried forward, though we note this approach is not without
its limitations [25]. A two-tailed p value of less than 0.05
was considered to indicate statistical significance. All
analyses were performed with the Statistical Package for
Social Science (SPSS for windows version 18.0, Chicago,
IL, USA). Correlation assessments were conducted and
were expressed as R and p values. Food diary analysis was
completed using the Microdiet© Plus for Windows
(version 1.2, 2001).
Results
The flow diagram in Figure 1 demonstrates the progress
through the phases of the open parallel randomised trial
for both groups. Thirty three patients (26 female) con-
sented to take part in the study, mean age 56.7 years.
Twenty subjects (16 female) with a mean age 58.6 years
completed the study. At baseline they had a mean
HARQ score of 30/70. Baseline parameters of the pa-
tients are depicted in Table 1 and the change in parame-
ters from baseline are depicted in Table 2.
Mean weight loss was 3.1 kg representing a 0.4%
(range -3 – 11%) weight loss of all patients (p < 0.001). All
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Figure 1 Flow diagram of the progress through the phases of the stuin patients completing the programme was 3.9%. In both
intervention arms there was a similar and significant
weight loss. For the EP group mean reduction was 3.2 kg
(p = 0.001), and for the anti-reflux diet group a mean
reduction of 2.63 kg (p = 0.012).
At baseline, mean BMI 34 kg/m2 (range 26-50.8 kg/m2).
There were similar and significant changes from baseline to
end of study for the EP group (mean reduction 1.3 kg/m2
(p = 0.001)), and for the anti-reflux diet group (mean
reduction 1.2 kg/m2 (p = 0.011)) (Table 1; Figures 2a, 2b).
Sixteen patients submitted food diaries at both the
start and end of the trial. 10 of these subjects were in
the EP group. Surprisingly for both groups the food
diary analysis from baseline to end of study, showed an
increase in both calorie and fat intakes, though these in-
creases were not significant. For the EP group the mean
increase in calories consumed was 96.7 kcal (p = 0.4) and
for the anti-reflux diet group was 234.5 kcal (p = 1.0).
The mean increase in fat intake for the EP group was
2.5 g (p = 0.8) and for the anti-reflux diet group was
7.3 g (p = 0.8) (Table 2).
The mean change in LCQ score was 3.1 units in all
the consented patients. There was an increase (improve-
ment in LCQ) was similar (3.6 units for the EP group
and 2.5 units for the anti-reflux diet group) (Table 2).
All of the patients who completed the study achieved an
improvement in their cough score (range 2.5 to 7.7)
above the minimal clinically significant (MCS) score of
1.3 [26]. Secondary correlation analysis of the baseline
data from the food diary showed that high calorie and fat
intakes were significantly associated with a worse quality
of life score (calories (r = -0.24; P < 0.001); fat (r = -0.36;
P = 0.001)) (Figure 3a, 3b).ts referred 











- 4 no reason given (2F/2M) 
- 2 family reasons (2F)
-1 not able to follow diet 
(1F)
- 1 pregnant (1F)
dy.
Table 1 Baseline parameters of all consented, energy prescription and reflux diet patients in the study
Parameter Consented patients (N = 33) Energy prescription Gp patients (N = 18) Reflux diet Gp patients (N = 15)
Age* 58.6 (±13.4) 58.0 (±14) 59.0 (±13)
Sex 4 M/16 F 3 M/10 F 1 M/6 F
Baseline weight (Kg)* 89.0 (±17.4) 89.9 (±13.7) 87.5 (±24.0)
Baseline BMI (kg/m2)^ 34.0 (29.8, 35.3) 33.6 (30.5, 34.9) 31.8 (28.5, 35.6)
Baseline LCQ score* 14.4 (±3.8) 6.8 (±2.6) 2.58 (±1.61)
Baseline Kcal^ 1266.7 (1138.5, 1532.9) 1396.7 (1147.9, 1615.9) 1165.9 (1138.5, 1336.9)
Baseline fat^ 41.8 (32.8, 57.1) 51.2 (31.6, 64.4) 41.4 (35.6, 65.6)
*Expressed as mean (± standard deviation).
^Expressed as median (interquartile range).
Abbreviations: Gp Group, N number, M male, F female, Kg kilograms, BMI body mass index, kg/m2 kilogram per metres squared, LCQ Leicester cough questionnaire,
Kcal Kilocalories.
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Chronic cough associated with gastro oesophageal reflux
is a common but frequently under diagnosed condition.
This is due to the ‘atypical’ presentation with symptoms
of non-peptic, extra-oesophageal origin. To define this
syndrome a variety of questionnaires such as the Reflux
Symptom Index have been developed. In this study we
have used the HARQ, a questionnaire developed specif-
ically to quantify the symptoms of airway reflux under-
lying cough hypersensitivity. Our patients all exhibited
HARQ scores above the cut off of 13/70 required to
diagnose airway reflux and represent a distinctive popu-
lation of patients with reflux induced cough hypersensi-
tivity syndrome [19].
There is a dearth of treatment options available to pa-
tients with airway reflux. Pharmacotherapy with conven-
tional acid suppression has recently been shown to be
no more effective than placebo [27] presumably because
of the non-peptic nature of the tussive stimulus. Pro-
motility agents such as metoclopramide, domperidone
and macrolides have been advocated, but there is a lack
of randomised control trials supporting their use. The
only evidence based therapy is oral opiates [28], which
do not treat reflux but suppresses cough reflex hyper-
sensitivity centrally.
Non-pharmacological treatment has been shown to be
effective. Specific cough related speech therapy has beenTable 2 Change in parameters for the intention to treat coho
Parameter Energy prescription diet
Baseline End of stud
Baseline weight (Kg)* 89.9 (±13.7) 85.9 (±15.4)
Baseline BMI (kg/m2)^ 33.6 (30.5, 34.9) 32.5 (28.3, 34
Baseline LCQ score* 6.8 (±2.6) 6.2 (±2.5)
Baseline Kcal^ 1396.7 (1147.9, 1615.9) 1493.4 (1147
Baseline fat^ 51.2 (31.6, 64.4) 53.7 (48.6, 64
*Expressed as mean (± standard deviation).
^Expressed as median (interquartile range).
Abbreviations: Gp Group, N number, M male, F female, Kg kilograms, BMI body mass
Kcal Kilocalories.demonstrated to diminish cough reflex sensitivity and
improve quality of life [29]. We had previously observed a
significant relationship between obesity and chronic cough
in a survey of the general population [10]. This observa-
tion is mirrored in studies showing an increase of obesity
related GORD [30]. This led us to hypothesize that weight
reduction may offer a further non-pharmacological treat-
ment option in obese chronic cough patients.
We have tested this hypothesis by comparing two diet-
ary measures that may aid resolution of airway reflux.
The traditional ‘textbook’ GORD anti-reflux diet was
compared to an EP diet, targeting weight control. We
showed no difference between these two strategies, both
of which produced weight loss and a reduction in cough
score. Surprisingly, percentage weight loss was slightly
greater in the traditional ‘textbook’ GORD anti-reflux
diet group, and there appears to be little evidence that
dietary intervention needs to follow a restriction of foods
of any particular ‘refluxogenic’ type for improvement to
be manifest.
Analyses of the food diaries at baseline showed current
high intakes of calories and fat had an adverse effect on
cough quality of life suggesting that this may contribute
to chronic cough. Other studies in GORD have demon-
strated an association of a high fat intake and the occur-
rence of reflux [11,12]. Moreover, weight loss has been
shown to improve pH profiles and symptoms in GORDrts for the energy prescription and reflux diets
Reflux diet
y Baseline End of study
87.5 (±24.0) 82.1 (±24.0)
.3) 31.8 (28.5, 35.6) 29.7 (26.1, 34.4)
2.58 (±1.61) 13.5 (±3.7)
.9, 1615.9) 1165.9 (1138.5, 1336.9) 1400.4 (1276.9, 1552.0)
.4) 41.4 (35.6, 65.6) 48.7 (47, 71.2)











































Figure 2 Change in weight and BMI from baseline to end of study. (a) weight (kg). (b) BMI (kg/m2).
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observation may be that the high fat and calorie intake
leads to weight gain which in turn causes reflux. This is
supported by research suggesting that reflux is more
prevalent in the overweight and obese population rather
than the lean [5-8].
Since there was no non-intervention group in our
study it is impossible to say whether the dietary mea-
sures directly contributed to the improvement in cough
quality of life. Chronic cough may follow a waxing and
waning course [31] and it is possible that the improve-
ment in cough score may be explicable by regression to
the mean from the pre study baseline. The effectiveness
of a dietary intervention on cough however, with all ofthe patients who completed the study showing a greater
than MCS improvement in cough quality of life score,
would tend to suggest a clinically important effect of this
intervention.
In interpreting our observations one needs to take into
account some limitations in our study. Firstly, recruit-
ment to the study was slower than expected due to 21
patients who declined to take part from the outset des-
pite encouragement from the medical team. Patients in
the Hull Cough Clinic often request advice on lifestyle
modification and it was perhaps surprising that these
proposals were rejected when offered. There are many
factors that contribute to a person’s motivation to lose
weight which include their readiness for change and
Baseline LCQ score





































Figure 3 Correlations of calorie and fat intakes with LCQ score at baseline, (a) calorie (kcal). (b) fat (g).
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health. As our study required that the patient to be
reviewed monthly over a seven month period, study dur-
ation may have been a contributing factor. An individ-
ual’s perceived lack of time is one of the barriers to
change [32]. NICE Guidelines on Obesity however, rec-
ommends that ‘regular, non-discriminatory long term
follow up by a trained professional should be offered’
[32]. It is possible that these recommendations may
hamper rather than aid compliance. Secondly, as with
many studies into the effect of lifestyle change, this study
could not use a blinded methodology. As a consequence
all patients recruited were aware of our hypothesis that
weight loss would contribute to a reduction in reflux
cough. Thirteen of the recruited subjects dropped out
of the study, with 8 subjects providing no reason. Anumber who completed the study stated that they
were disappointed to be allocated into what was per-
ceived as the control group, i.e. the traditional anti-reflux
diet. Moreover, the overall number of patients who com-
pleted the study was small. Thirdly, we did not perform
objective assessments of GORD since existing techniques
are poorly correlated with non acid reflux as determined
by symptom assessment. There is an urgent need for such
measurements to be developed. Additionally we did not
study objective parameters of cough and we acknowledge
this as a weakness of the study. The above may have
diminished our understanding of the pathobiological basis
of the cough reduction seen. In particular, Obstructive
Sleep Apnoea (OSA) in obese subjects can rarely pre-
cipitate cough [33], and maybe improved by weight
reduction. While we have shown statistical significance
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be required to draw definitive conclusions.
Conclusion
In this study we report for the first time if weight loss is
achieved irrespective of diet there is a reduction on
cough quality of life symptoms. Furthermore, we have
shown a strong correlation between a high calorie and
fat intake with LCQ score. Simply asking subjects to lose
weight by reducing fat and calorie intake may be a useful
strategy for the management of intractable cough in
primary care.
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